经皮椎体成形术病人椎体骨折的临床特点分析  

The analysis of characteristics of patients with vertebral fracture and percutaneous vertebroplasty(PVP)

作　　者：金晖[1] 蔡若男[1] 何仕城[2] 邓钢[2] 

机构地区：[1]东南大学附属中大医院内分泌科,南京210009 [2]东南大学附属中大医院介入血管科,南京210009

出　　处：《中华骨质疏松和骨矿盐疾病杂志》2009年第3期172-175,共4页Chinese Journal Of Osteoporosis And Bone Mineral Research

摘　　要：目的了解经皮椎体成形术治疗患者椎体骨折的临床特点。方法对2006年5月至2009年6月间在我院介入血管科行经皮椎体成形术的309例病例通过病历查询的方式获取资料,记录患者的性别、年龄、诊断、骨折诱因、慢性病史、手术史、药物治疗等。结果 309例椎体骨折患者中骨质疏松性椎体压缩性骨折183例,平均年龄为72.42±8.49岁,转移癌101例,平均年龄为60.08±12.62岁,血管瘤6例,腰椎良性病变1例,车祸、高空坠落等外伤致椎体压缩性骨折18例。骨质疏松性椎体骨折患者女性多于男性,以胸12、腰1、腰2椎体骨折多见,多合并高血压、糖尿病、类风湿关节炎、服用激素等慢性病史,骨质疏松骨折的诱因以跌倒为主。在病程中会多次发生多个椎体骨折,需多次手术。结论重视对骨质疏松危险因素的防治,并预防椎体骨折的再次发生。Objective To study clinical characteristics of patients who suffered from vertebral fracture and had percutaneous vertebroplasty operation. Methods 309 cases with vertebral fracture and percutaneous vertebroplasty operation were reviewed from May, 2006 to June, 2009. Information was got through case evaluation, including sex, age, diagnosis, induced factors of fracture, history of chronic disease, history of operation, and medication treatment. Restilts Among the 309 patients, there were 181 cases of osteoporotic vertebral fractures, average age 72. 42 ± 8.49 years old, 101 cases of vertebral metastases, average age 60. 08 ± 12. 62 years old, 6 cases of vertebral hemangioma, one case of spinal benign lesion, 18 cases of trauma. The female vertebral fracture patients were more than those of male, and T12, L1,L2 were the most frequent sites of vertebral fracture. The chronic diseases were complicated, for example, hypertension, diabetes mellitus, rheumatoid arthritis, and using of glucocorticoids. Falls were the main induced factors of vertebral fracture. In the duration of osteoporosis, patients often suffer from multi-vertebral fracture, and operations more than once were needed. Conclusion It is important to prevent and treat the risk factors of osteoporosis, in order to reduce the occurrence of vertebral fracture.

关 键 词：骨质疏松 椎体骨折 经皮椎体成形术 

分 类 号：R683.2[医药卫生—骨科学]